scholarly journals Measuring Quality of Life in Children With Obstructive Sleep Disorders

2000 ◽  
Vol 126 (12) ◽  
pp. 1423 ◽  
Author(s):  
Lianne M. de Serres ◽  
Craig Derkay ◽  
Susan Astley ◽  
Richard A. Deyo ◽  
Richard M. Rosenfeld ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Sleep Disorders ◽  
Obstructive Sleep

scholarly journals The prevalence of common sleep disorders in young adults: a descriptive population-based study

SLEEP ◽  
2020 ◽  
Vol 43 (10) ◽  
Author(s):  
Nigel McArdle ◽  
Sarah V Ward ◽  
Romola S Bucks ◽  
Kathleen Maddison ◽  
Anne Smith ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Young Adults ◽  
Sleep Disorders ◽  
Sleep Disorder ◽  
Restless Legs Syndrome ◽  
Survey Methods ◽  
Apnea Hypopnea Index ◽  
Restless Legs ◽  
Obstructive Sleep

Abstract Sleep disorders in adults are associated with adverse health effects including reduced quality of life and increased mortality. However, there is little information on sleep disorders in young adults. A cross-sectional observational study was undertaken in 1,227 young adults participating in the Western Australian Pregnancy (Raine) Study (2012–2014) to describe the prevalence of common sleep disorders. In-laboratory polysomnography (PSG) and validated survey methods were used, including the Epworth Sleepiness Scale, Pittsburgh Sleep Symptom Questionnaire-Insomnia, and International Restless Legs Syndrome Study Group criteria. A total of 1,146 participants completed a core questionnaire, 1,051 completed a sleep-focused questionnaire and 935 had analyzable PSG data. Participants had a mean age of 22.2 years and female to male ratio of 1.1 to 1. The respective sleep disorder prevalences in females and males were: obstructive sleep apnea (OSA) (apnea-hypopnea index [AHI]: ≥5 events/hour) 14.9% (95% CI: 11.8–18.5) and 26.9% (95% CI: 22.9–31.2); chronic insomnia, 19.3% (95% CI: 16.7–23.9) and 10.6% (95% CI: 8.3–13.9); restless legs syndrome, 3.8% (95% CI: 2.4–5.6) and 1.9% (95% CI: 0.9–3.4); and abnormal periodic leg movements during sleep (>5 movements/hour), 8.6% (95% CI: 6.3–11.5) and 9.6% (95% CI: 7.1–12.7). There were statistically significant differences in prevalence between sexes for OSA and insomnia, which persisted after adjustment for body mass index and education. In those with complete data on all sleep-related assessments (n = 836), at least one sleep disorder was present in 41.0% of females and 42.3% of males. Sleep disorders are very common in young adults. Health practitioners should be aware of these high prevalences, as early identification and treatment can improve quality of life and may reduce later morbidity and mortality.

Idiopathic hypersomnia, Kleine–Levin syndrome, and symptomatic hypersomnias

2017 ◽  
Author(s):  
Michel Billiard ◽  
Yves Dauvilliers
Keyword(s):  
Quality Of Life ◽  
Obstructive Sleep Apnea ◽  
Sleep Disorders ◽  
Sleep Apnea Syndrome ◽  
Medical Disorder ◽  
Obstructive Sleep ◽  
Idiopathic Hypersomnia ◽  
Apnea Syndrome

Besides obstructive sleep apnea syndrome and narcolepsy, there are a number of other causes of excessive daytime sleepiness, listed in the International Classification of Sleep Disorders, third edition, as central disorders of hypersomnolence. They include primary sleep disorders such as idiopathic hypersomnia, Kleine-Levin syndrome and a number of hypersomnias due to a medical disorder, a medication, or a substance, associated with a psychiatric disorder, or due to insufficient sleep. Idiopathic hypersomnia and Kleine–Levin syndrome have attracted much interest in recent years, and an overview of recent progresses is presented in this chapter. The symptomatic hypersomnias are less well known to sleep physicians and often neglected by specialists, either internists or psychiatrists, although they may seriously impact the quality of life of patients

scholarly journals Modafinil in the treatment of selected sleep disorders

2021 ◽  
Vol 21 (3) ◽  
pp. 213-218
Author(s):  
Wacław Dyrda ◽  
Daria Smułek ◽  
Adam Wichniak ◽  
Keyword(s):  
Quality Of Life ◽  
Sleep Disorders ◽  
Sleep Disorder ◽  
Shift Work ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Shift Work Sleep Disorder ◽  
Obstructive Sleep ◽  
Idiopathic Hypersomnia

Until 2010, modafinil, which is a wakefulness promoting agent, was approved in Europe for a wider spectrum of indications, such as narcolepsy, idiopathic hypersomnia, obstructive sleep apnoea and shift work sleep disorder. Currently, it is registered by the European Medicines Agency only for the treatment of narcolepsy, and is used as an off-label therapy in other sleep disorders. This paper presents the efficacy of modafinil in selected sleep disorders. Modafinil remains first-choice treatment for narcolepsy. It reduces the frequency of bouts of inadvertent sleep and nap episodes, the duration and intensity of daytime hypersomnolence, and also significantly improves the quality of life of patients. However, it is associated with only a slight improvement in cataplexy and other symptoms. In idiopathic hypersomnia, modafinil reduces the frequency of naps and unintentional sleep episodes, as well as subjective sleepiness measured with the Epworth Sleepiness Scale. Furthermore, the drug is used to treat hypersomnia from obstructive sleep apnoea in the case of lack of improvement despite optimal positive airway pressure therapy. Modafinil is also approved by the U.S. Food and Drug Administration for the treatment of shift work sleep disorder. The drug has been shown to reduce the level of somnolence, but it has not been found to reduce unintentional sleep episodes, reported mistakes or accidents at work. Given the strong negative impact of hypersomnolence on performance at work and school, the risk of accidents and the quality of life, the risk-benefit assessment of modafinil often justifies its use in the treatment of hypersomnolence also outside the approved indications.

scholarly journals Sleep disorders in people with type 2 diabetes and associated health outcomes: a review of the literature

Diabetologia ◽  
2021 ◽  
Author(s):  
Samantha B. J. Schipper ◽  
Maaike M. Van Veen ◽  
Petra J. M. Elders ◽  
Annemieke van Straten ◽  
Ysbrand D. Van Der Werf ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Type 2 Diabetes ◽  
Glycaemic Control ◽  
Health Outcomes ◽  
Sleep Disorders ◽  
Review Of The Literature ◽  
Obstructive Sleep ◽  
Diabetes Progression

AbstractSleep disorders are linked to development of type 2 diabetes and increase the risk of developing diabetes complications. Treating sleep disorders might therefore play an important role in the prevention of diabetes progression. However, the detection and treatment of sleep disorders are not part of standardised care for people with type 2 diabetes. To highlight the importance of sleep disorders in people with type 2 diabetes, we provide a review of the literature on the prevalence of sleep disorders in type 2 diabetes and the association between sleep disorders and health outcomes, such as glycaemic control, microvascular and macrovascular complications, depression, mortality and quality of life. Additionally, we examine the extent to which treating sleep disorders in people with type 2 diabetes improves these health outcomes. We performed a literature search in PubMed from inception until January 2021, using search terms for sleep disorders, type 2 diabetes, prevalence, treatment and health outcomes. Both observational and experimental studies were included in the review. We found that insomnia (39% [95% CI 34, 44]), obstructive sleep apnoea (55–86%) and restless legs syndrome (8–45%) were more prevalent in people with type 2 diabetes, compared with the general population. No studies reported prevalence rates for circadian rhythm sleep–wake disorders, central disorders of hypersomnolence or parasomnias. Additionally, several cross-sectional and prospective studies showed that sleep disorders negatively affect health outcomes in at least one diabetes domain, especially glycaemic control. For example, insomnia is associated with increased HbA1c levels (2.51 mmol/mol [95% CI 1.1, 4.4]; 0.23% [95% CI 0.1, 0.4]). Finally, randomised controlled trials that investigate the effect of treating sleep disorders in people with type 2 diabetes are scarce, based on a small number of participants and sometimes inconclusive. Conventional therapies such as weight loss, sleep education and cognitive behavioural therapy seem to be effective in improving sleep and health outcomes in people with type 2 diabetes. We conclude that sleep disorders are highly prevalent in people with type 2 diabetes, negatively affecting health outcomes. Since treatment of the sleep disorder could prevent diabetes progression, efforts should be made to diagnose and treat sleep disorders in type 2 diabetes in order to ultimately improve health and therefore quality of life. Graphical abstract

Sleep Disorders in Pregnancy, Influencing Factors and Quality of Life

2021 ◽  
Author(s):  
Nezaket Kadıoğlu ◽  
Umit Yasemin Sert ◽  
Seval Gundogdu Sariaslan ◽  
Konul Mursel ◽  
Sevki Celen
Keyword(s):  
Quality Of Life ◽  
Pregnant Women ◽  
Sleep Disorders ◽  
Sleep Disturbances ◽  
Sleep Apnea Syndrome ◽  
Berlin Questionnaire ◽  
Life Questionnaire ◽  
Obstructive Sleep ◽  
In Pregnancy

Abstract Aim In our study, the frequency of sleep disturbances in pregnancy, the reasons underlying the low quality of sleep, clinical factors, and the effects on quality of life were investigated. Methods The study was planned as a prospective study and included 189 pregnant women. Clinical features, laboratory results, socio-demographic status, obstetric and medical anamnesis were evaluated. The Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, the Berlin Questionnaire, Beck Depression Inventory, SF-36 quality-of-life questionnaire, and restless leg syndrome (RLS) diagnosis criteria were used for data collection. Results We investigated sleep disorders in 110 pregnant women (58.2%). A history of premenstrual syndrome and patients with hyperemesis gravidarum, obstructive sleep apnea syndrome, Vitamin B12 deficiency, and higher TSH levels in the laboratory were found to be associated with sleep disorders. Sleep disorders and daytime sleepiness were associated with depression, physical and social functioning, pain, and disturbance in general health perception. The number of pregnant women who had two or more RLS complaints was 84 (44%). Conclusion The results of our study show that sleep disorders in pregnancy can be managed with easily applicable methods according to the risk factors and related problems.

scholarly journals The State of Art on Co-Morbid Insomnia and Sleep Apnea (COMISA)

2021 ◽  
Vol 11 (8) ◽  
pp. 1079
Author(s):  
Luigi De Gennaro
Keyword(s):  
Quality Of Life ◽  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Sleep Disorders ◽  
Sleep Disturbances ◽  
Nocturnal Sleep ◽  
Daytime Activity ◽  
Obstructive Sleep ◽  
State Of Art

Insomnia and obstructive sleep apnea (OSA) are two prevalent sleep disorders which share nocturnal sleep disturbances, impairments to daytime activity and quality of life, and high healthcare and social costs [...]

Impact of Adenotonsillectomy on Quality of Life in Children With Obstructive Sleep Disorders

2002 ◽  
Vol 128 (5) ◽  
pp. 489 ◽  
Author(s):  
Lianne M. de Serres ◽  
Craig Derkay ◽  
Kathleen Sie ◽  
Michael Biavati ◽  
Jacqueline Jones ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Sleep Disorders ◽  
Obstructive Sleep
Sign in / Sign up

Export Citation Format

Share Document